Susan E. Wilson

CD47 limits antibody dependent phagocytosis against non‐malignant B cells

R. Herbst, Yue Wang, S. Gallagher, 2017, Molecular immunology.

Biologicals and Immunologicals Overview: Recent developments in macrolide immunosuppressants

R. Aston, Susan E. Wilson, 1994 .

Synergistic Anti-Tumor Responses After Administration of Agonistic Antibodies to CD40 and IL-2: Coordination of Dendritic and CD8+ Cell Responses 1

J. Wigginton, T. Sayers, T. Back, 2003, The Journal of Immunology.

Phase I Studies of Interleukin (IL)-2 and Rituximab in B-Cell Non-Hodgkin’s Lymphoma

A. Difrancesco, J. Gockerman, A. Levine, 2004, Clinical Cancer Research.

Recombinant Interleukin-2 Significantly Augments Activity of Rituximab in Human Tumor Xenograft Models of B-cell Non-Hodgkin Lymphoma

Yan Tang, J. Kunich, B. Jallal, 2007, Journal of immunotherapy.

Concordance of human leukocyte antigen haplotype‐sharing, CD4 decline and AIDS in hemophilic siblings

J. Goedert, W. Blattner, M. Carrington, 1995, AIDS.

Cell Responses + and CD8 CD40 and IL-2: Coordination of Dendritic Administration of Agonistic Antibodies to Synergistic Anti-Tumor Responses After

J. Wigginton, T. Sayers, T. Back, 2003 .